Pfizer and Merck’s diabetes contender looks to challenge Jardiance
Merck and Pfizer have Boehringer and Lilly in their sights with ertugliflozin
X
Pfizer and Merck’s diabetes contender looks to challenge Jardiance
https://pharmaphorum.com/news/pfizer-merck-file-diabetes-contender-us-eu/